Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Radiopharmaceuticals
- Radiation Therapy
Chapter 3 Market Dynamics
- Radiotherapy Market Drivers
- Rising Prevalence of Cancer
- Early Screening
- Advances in Radiation Therapy Planning and Delivery Systems
- Increasing Demand in Developing Regions
- Applications Beyond Oncology
- Radiotherapy Market Restraints
- Shortage of Skilled Professionals
- Limited Effectiveness against Metastatic Cancer
- Trends in Radiotherapy Market
- Growing Use of Advanced Imaging and Hypofractionation
- Adaptive Radiation Therapy
- Radiopharmaceutical Market Drivers
- Rising Prevalence of Chronic Diseases
- Focus on Early Diagnosis and Screening
- Precision Medicine
- Nuclear Imaging Technologies
- Increasing Investments
- Radiopharmaceutical Market Restraints
- Manufacturing and Supply Chain Issues
- Infrastructure and Specialized Imaging Equipment Requirements
- Trends in the Radiopharmaceutical Market
- Theranostics
- PET/MRI Hybrid Imaging
Chapter 4 Emerging Technologies and Developments
- Emerging Technologies in Radiation Therapy
- Artificial Intelligence
- Online Adaptive Radiation Therapy
- MR-Linac
- FLASH Radiation Therapy
- Emerging Technologies in Radiopharmaceuticals
- Targeted Alpha Therapy
Chapter 5 Market Segmentation Analysis
- Radiation Therapy Market, by Product Type
- Market Overview
- Market Size and Forecast
- Radiation Therapy Market, by Technology Type
- Market Size and Forecast
- External Beam Radiation Therapy
- EBRT by Technique Type
- EBRT, by System Type
- EBRT, by Application
- Internal Beam Radiation Therapy
- IBRT, by Technique Type
- IBRT, by Product Type
- IBRT, by Application
- Radiation Therapy Market, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World (Row)
- Radiopharmaceuticals Market, by Product Type
- Market Size and Forecast
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Radiopharmaceuticals Market, by Application
- Market Size and Forecast
- Oncology
- Cardiology
- Neurology
- Other Applications
- Radiopharmaceuticals Market, by Production Method
- Market Overview
- Nuclear Reactors
- Cyclotrons
- Radionuclide Generators
- Market Size and Forecast
- Radiopharmaceuticals Market, by Region
- North America
- Europe
- Asia-Pacific
- RoW
Chapter 6 Competitive Intelligence
- Leading Radiotherapy Device Manufacturers
- Leading Companies in Radiopharmaceuticals
List of Tables
Summary Table: Global Market for Radiation Therapy Products and Radiopharmaceuticals, by Type, Through 2029
Table 1: Acquisitions and Funding in the Radiopharmaceuticals Market
Table 2: Comparison of CT and MRI for Radiotherapy Treatment
Table 3: Targeted Alpha Therapies in Development, 2024
Table 4: Global Market for Radiation Therapy Products and Services, by Product Type, Through 2029
Table 5: Global Market for Radiation Therapy Products and Services, by Technology Type, Through 2029
Table 6: Global Market for EBRT Products and Services, by Technique Type, Through 2029
Table 7: Specialized Stereotactic Radiosurgery Systems
Table 8: Global Market for EBRT Products and Services, by System Type, Through 2029
Table 9: Global Market for Particle Therapy Products and Services, by System Type, Through 2029
Table 10: Global Market for EBRT Products and Services, by Application, Through 2029
Table 11: Estimated Number of New Cancer Cases, by Cancer Site, 2022-2045
Table 12: Commonly Used Radionuclides (Radiation Sources) Half-Life for Brachytherapy
Table 13: Global Market for Internal Radiation Therapy Products and Services, by Technique Type, Through 2029
Table 14: Global Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
Table 15: Estimated New Cancer Cases, by Cancer Site, 2022-2045
Table 16: Global Market for Internal Beam Radiation Therapy Products and Services, by Application, Through 2029
Table 17: Global Market for Radiation Therapy Products and Services, by Region, Through 2029
Table 18: North American Market for Radiation Therapy Products and Services, by Product Type, Through 2029
Table 19: North American Market for Radiation Therapy Products and Services, by Country, Through 2029
Table 20: North American Market for Radiotherapy Products and Services, by Technology Type, Through 2029
Table 21: North American Market for EBRT Products and Services, by System Type, Through 2029
Table 22: North American Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
Table 23: European Market for Radiation Therapy Products and Services, by Product Type, Through 2029
Table 24: European Market for Radiation Therapy Products and Services, by Country, Through 2029
Table 25: European Market for Radiotherapy Products and Services, by Technology Type, Through 2029
Table 26: European Market for EBRT Products and Services, by System Type, Through 2029
Table 27: European Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
Table 28: Asia-Pacific Market for Radiation Therapy Products and Services, by Product Type, Through 2029
Table 29: Asia-Pacific Market for Radiation Therapy Products and Services, by Country, Through 2029
Table 30: Asia-Pacific Market for Radiotherapy Products and Services, by Technology Type, Through 2029
Table 31: Asia-Pacific Market for EBRT Products and Services, by System Type, Through 2029
Table 32: Asia-Pacific Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
Table 33: Global Cancer Incidence, by Region, 2022 and 2045
Table 34: RoW Market for Radiation Therapy Products and Services, by Product Type, Through 2029
Table 35: RoW Market for Radiation Therapy Products and Services, by Subregion, Through 2029
Table 36: RoW Market for Radiotherapy Products and Services, by Technology Type, Through 2029
Table 37: RoW Market for EBRT Products and Services, by System Type, Through 2029
Table 38: RoW Market for Internal Radiation Therapy Products and Services, by Product Type, Through 2029
Table 39: Global Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 40: Radioisotopes Used in Diagnostic Radiopharmaceuticals
Table 41: Comparison of PET and SPECT
Table 42: FDA-approved PET Radiopharmaceuticals
Table 43: FDA-approved SPECT and Other Diagnostic Radiopharmaceuticals
Table 44: Global Market for Diagnostic Radiopharmaceuticals, by Product Type, Through 2029
Table 45: Comparison of Alpha and Beta Particles
Table 46: FDA-approved Therapeutic Radiopharmaceuticals
Table 47: Global Market for Therapeutic Radiopharmaceuticals, by Product Type, Through 2029
Table 48: Global Market for Radiopharmaceuticals, by Application, Through 2029
Table 49: Radiopharmaceuticals for CNS Imaging in Clinical Development
Table 50: Global Market for Radiopharmaceuticals, by Production Method, Through 2029
Table 51: Global Market for Radiopharmaceuticals, by Region, Through 2029
Table 52: North American Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 53: European Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 54: Asia-Pacific Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 55: RoW Market for Radiopharmaceuticals, by Product Type, Through 2029
Table 56: Rank of Companies in the Global Radiopharmaceuticals Market, 2023
Table 57: Report Sources
Table 58: Abbreviations Used in This Report
Table 59: Accuray Inc.: Company Snapshot
Table 60: Accuray Inc.: Financial Performance, FY 2022 and 2023
Table 61: Accuray Inc.: Product Portfolio
Table 62: Accuray Inc.: News/Key Developments, 2022 and 2023
Table 63: Cardinal Health: Company Snapshot
Table 64: Cardinal Health: Financial Performance, FY 2022 and 2023
Table 65: Cardinal Health: Product Portfolio
Table 66: Cardinal Health: News/Key Developments, 2021
Table 67: Curium: Company Snapshot
Table 68: Curium: Product Portfolio
Table 69: Curium: News/Key Developments, 2022 and 2023
Table 70: Elekta: Company Snapshot
Table 71: Elekta: Financial Performance, FY 2021 and FY 2022
Table 72: Elekta: Product Portfolio
Table 73: Elekta: News/Key Developments, 2021-2023
Table 74: GE HealthCare: Company Snapshot
Table 75: GE HealthCare: Financial Performance, FY 2022 and 2023
Table 76: GE HealthCare: Product Portfolio
Table 77: GE HealthCare: News/Key Developments, 2021-2023
Table 78: Lantheus: Company Snapshot
Table 79: Lantheus: Financial Performance, FY 2022 and 2023
Table 80: Lantheus: Product Portfolio
Table 81: Lantheus: News/Key Developments, 2022 and 2023
Table 82: Novartis AG: Company Snapshot
Table 83: Novartis AG: Financial Performance, FY 2022 and 2023
Table 84: Novartis AG: Product Portfolio
Table 85: Novartis AG: News/Key Developments, 2022 and 2023
Table 86: Siemens Healthineers AG: Company Snapshot
Table 87: Siemens Healthineers AG: Financial Performance, FY 2022 and 2023
Table 88: Siemens Healthineers AG: Product Portfolio
Table 89: Siemens Healthineers AG: News/Key Developments, 2022-2024
List of Figures
Summary Figure: Global Market for Radiation Therapy Products and Radiopharmaceuticals, by Type, 2021-2029
Figure 1: Types of Radiation
Figure 2: Radiation Therapy and Radiopharmaceuticals Market Dynamics
Figure 3: Estimated New Cancer Cases, 2022, 2045 and 2050
Figure 4: Cancer Radiotherapy Treatment Systems, by Region, 2021
Figure 5: Global Incidence of Cancer, by Region, 2022 and 2045
Figure 6: Global Market Shares of Radiation Therapy Products and Services, by Product Type, 2023
Figure 7: Global Market Shares of Radiation Therapy Products and Services, by Technology Type, 2023
Figure 8: Global Market Shares of EBRT Products and Services, by Technique Type, 2023
Figure 9: Global Market Shares of EBRT Products and Services, by System Type, 2023
Figure 10: Global Market Shares of Particle Therapy Products and Services, by System Type, 2023
Figure 11: Global Market Shares of EBRT Products and Services, by Application, 2023
Figure 12: Global Market Shares of Internal Radiation Therapy Products and Services, by Technique Type, 2023
Figure 13: Global Market Shares of Internal Radiation Therapy Products and Services, by Product Type, 2023
Figure 14: Global Market Shares of Internal Radiation Therapy Products and Services, by Application, 2023
Figure 15: Global Market for Radiation Therapy Products and Services, by Region, 2021-2029
Figure 16: Global Market Shares of Radiation Therapy Products and Services, by Region, 2023
Figure 17: Global Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 18: Global Market Shares of Diagnostic Radiopharmaceuticals, by Product Type, 2023
Figure 19: Global Market Shares of Therapeutic Radiopharmaceuticals, by Product Type, 2023
Figure 20: Global Market Shares of Radiopharmaceuticals, by Application, 2023
Figure 21: Global Market Shares of Radiopharmaceuticals, by Production Method, 2023
Figure 22: Global Market Shares of Radiopharmaceuticals, by Region, 2023
Figure 23: North American Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 24: European Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 25: Asia-Pacific Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 26: RoW Market Shares of Radiopharmaceuticals, by Product Type, 2023
Figure 27: Global Market Shares of Radiation Therapy Devices, by Company, 2023
Figure 28: Global Market Shares of Radiopharmaceuticals, by Company, 2023
Figure 29: Accuray Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 30: Accuray Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 31: Cardinal Health: Revenue Shares, by Business Unit, FY 2023
Figure 32: Cardinal Health: Revenue Shares, by Country/Region, FY 2023
Figure 33: Elekta: Revenue Shares, by Business Unit, FY 2022
Figure 34: Elekta: Revenue Shares, by Country/Region, FY 2022
Figure 35: GE HealthCare: Revenue Shares, by Business Unit, FY 2023
Figure 36: GE HealthCare: Revenue Shares, by Country/Region, FY 2023
Figure 37: Lantheus: Revenue Shares, by Business Unit, FY 2023
Figure 38: Novartis AG: Revenue Shares, by Business Unit, FY 2023
Figure 39: Novartis AG: Revenue Shares, by Country/Region, FY 2023
Figure 40: Siemens Healthineers AG: Revenue Shares, by Business Unit, FY 2023
Figure 41: Siemens Healthineers AG: Revenue Shares, by Country/Region, FY 2023
